Year,Rank_nr,Company,Industry,Country,Sales,Profits,Assets,Market_Value
2015,1820,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,751.0,-134.0,2490.0,18902.0
2016,1894,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,877.0,-171.8,3729.0,15157.0
2017,1930,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1113.0,-642.2,4024.0,15204.0
2018,1999,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1400.0,-144.9,4597.0,15623.0
2020,1916,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1788.0,114.0,4723.0,16557.0
2021,1453,BioMarin Pharmaceutical,Drugs & Biotechnology,United States,1842.0,859.1,5848.0,14437.0
